A detailed history of Eisler Capital (Uk) Ltd. transactions in Abbott Laboratories stock. As of the latest transaction made, Eisler Capital (Uk) Ltd. holds 5,934 shares of ABT stock, worth $672,262. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,934
Previous 79,717 92.56%
Holding current value
$672,262
Previous $8.28 Million 91.84%
% of portfolio
0.0%
Previous 0.05%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.07 - $118.13 $7.38 Million - $8.72 Million
-73,783 Reduced 92.56%
5,934 $676,000
Q2 2024

Aug 13, 2024

BUY
$100.73 - $112.44 $5.55 Million - $6.2 Million
55,135 Added 224.29%
79,717 $8.28 Million
Q1 2024

May 14, 2024

SELL
$109.52 - $120.96 $934,315 - $1.03 Million
-8,531 Reduced 25.76%
24,582 $2.79 Million
Q4 2023

Feb 13, 2024

SELL
$90.19 - $110.4 $11.5 Million - $14.1 Million
-128,052 Reduced 79.45%
33,113 $3.64 Million
Q3 2023

Nov 13, 2023

BUY
$95.53 - $114.62 $12.4 Million - $14.9 Million
129,710 Added 412.37%
161,165 $15.6 Million
Q2 2023

Aug 14, 2023

SELL
$100.78 - $112.29 $5.24 Million - $5.83 Million
-51,963 Reduced 62.29%
31,455 $3.43 Million
Q1 2023

May 12, 2023

BUY
$96.86 - $114.01 $8.08 Million - $9.51 Million
83,418 New
83,418 $8.45 Million
Q2 2022

Aug 12, 2022

SELL
$102.07 - $123.37 $5.21 Million - $6.3 Million
-51,092 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $5.83 Million - $7.1 Million
51,092 New
51,092 $6.05 Million
Q2 2021

Aug 13, 2021

SELL
$105.79 - $124.53 $2.45 Million - $2.89 Million
-23,174 Closed
0 $0
Q1 2021

Feb 24, 2022

BUY
$108.84 - $128.23 $2.52 Million - $2.97 Million
23,174 New
23,174 $2.78 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $198B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Eisler Capital (Uk) Ltd. Portfolio

Follow Eisler Capital (Uk) Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eisler Capital (Uk) Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Eisler Capital (Uk) Ltd. with notifications on news.